As PM Modi paid tribute to martyrs, and dignitaries, including Indonesian President Prabowo Subianto, participated in the ...

Union Budget 2025, to be presented on 1 February, is expected to focus on fuel price cuts, tax relief for the middle class, ...

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Announcements on cancer treatment are important, data shows. Data by Previu Health - a startup working in screening and ...

The third-quarter earnings season is in full swing, with around 59 companies set to release their results on Thursday.

Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

Biocon advanced 2.41% to Rs 397.20 after its board is scheduled to meet on Monday, 27 January 2025, to consider and approve the raising of funds on a private placement basis.

Synthetic biology startup Fermbox works in an asset-light business model and has raised $2.5 Mn so far to build its tech ...

The patent expiry of key drugs in 2025-26 will open up additional market space for Indian manufacturers of generics and ...

Biocon stock price is poised for a fresh breakout from its consolidation range of 320-395, following nearly three and a half ...

Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...